Repligen
RGEN
#2088
Rank
HK$77.98 B
Marketcap
HK$1,382
Share price
-3.16%
Change (1 day)
46.87%
Change (1 year)
Categories

Repligen (RGEN) - Net assets

Net assets on the balance sheet as of March 2026 : HK$16.50 Billion

According to Repligen 's latest financial reports the company has HK$16.50 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Repligen - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$HK$16.38 B7%
2024-12-31$HK$15.31 B-0.2%
2023-12-31$HK$15.34 B2.79%
2022-12-31$HK$14.92 B9.4%
2021-12-31$HK$13.64 B15.12%
2020-12-31$HK$11.85 B43.63%
2019-12-31$HK$8.25 B71.22%
2018-12-31$HK$4.82 B4.3%
2017-12-31$HK$4.62 B253.16%
2016-12-31$HK$1.30 B37.56%
2015-12-31$HK$0.95 B9.78%
2014-12-31$HK$0.86 B7.58%
2013-12-31$HK$0.80 B23.54%
2012-12-31$HK$0.65 B
2011-03-31$HK$0.52 B1.62%
2010-03-31$HK$0.51 B-4.14%
2009-03-31$HK$0.53 B7.39%
2008-03-31$HK$0.49 B150%
2007-03-31$HK$0.19 B0.69%
2006-03-31$HK$0.19 B4.65%
2005-03-31$HK$0.18 B-10.47%
2004-03-31$HK$0.21 B10.45%
2003-03-31$HK$0.19 B-7.17%
2002-03-31$HK$0.20 B-14.38%
2001-03-31$HK$0.24 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
HK$708.69 B 4,193.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$408.11 B 2,372.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$140.06 B 748.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$157.58 B 854.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-HK$0.15 Billion-100.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-HK$1.14 Billion-106.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$26.71 B 61.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$16.34 B-0.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$48.69 B 195.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$23.42 B 41.93%๐Ÿ‡บ๐Ÿ‡ธ USA